alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### James Nolan, Plaintiff-Appellee, v. Combined Insurance Company, Campbell, Lowrie, Lautermilch Corporation, Murphy & Miller, Inc., and Carrier Corporation, Defendants, and Hultgren Electric Corporation, Defendant-Appellant.

Gen. No. 52,551. (Abstract of Decision.)

First District, Third Division.

May 22, 1969.

Doyle, Berdelle & Taipey, of Chicago and Jerome H. Torshen, of Chicago (Jerome H. Torshen, of counsel), for appellant;

Horwitz, Anesi & Ozmon, of Chicago (Dario A. Garibaldi, Nat P. Ozmon and Richard A. Lewin, of counsel), for appellee.

Opinion by

MR. JUSTICE SCHWARTZ.

Not to be published in full.
# C_2015262EN.01002701.xml

| 10.8.2015 | EN | Official Journal of the European Union | C 262/27 |
| --- | --- | --- | --- |

10.8.2015

EN

Official Journal of the European Union

C 262/27

---

Judgment of the General Court of 24 June 2015 — GHC v Commission

(Case T-847/14) (1)

1

((Environment - Protection of the ozone layer - Fluorinated greenhouse gases - Regulation (EU) No 517/2014 - Placing of hydrofluorocarbons on the market - Determination of a reference value - Allocation of quotas - Duty to state reasons - Method of calculation))

(2015/C 262/36)

Language of the case: German

Parties

Parties

Applicant: GHC Gerling, Holz & Co. Handels GmbH (Hamburg, Germany) (represented by: D. Lang, lawyer)

Applicant:

Defendant: European Commission (represented by: C. Hermes and K. Mifsud-Bonnici, acting as Agents)

Defendant:

Re:

Re:

Application for annulment of Commission Implementing Decision 2014/774/EU of 31 October 2014 determining, pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council on fluorinated greenhouse gases, reference values for the period 1 January 2015 to 31 December 2017 for each producer or importer who has reported placing on the market hydrofluorocarbons under Regulation (EC) No 842/2006 of the European Parliament and of the Council (OJ 2014 L 318, p. 28), in so far as it concerns the applicant.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Commission Implementing Decision 2014/774/EU of 31 October 2014 determining, pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council on fluorinated greenhouse gases, reference values for the period 1 January 2015 to 31 December 2017 for each producer or importer who has reported placing on the market hydrofluorocarbons under Regulation (EC) No 842/2006 of the European Parliament and of the Council, is hereby annulled in so far as it concerns GHC Gerling, Holz & Co. Handels GmbH; |
| --- | --- |

1.

Commission Implementing Decision 2014/774/EU of 31 October 2014 determining, pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council on fluorinated greenhouse gases, reference values for the period 1 January 2015 to 31 December 2017 for each producer or importer who has reported placing on the market hydrofluorocarbons under Regulation (EC) No 842/2006 of the European Parliament and of the Council, is hereby annulled in so far as it concerns GHC Gerling, Holz & Co. Handels GmbH;

| 2. | The European Commission is ordered to pay the costs. |
| --- | --- |

2.

The European Commission is ordered to pay the costs.

---

(1)  OJ C 56, 16.2.2015.

1

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMO
POWER CORP.'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED DECEMBER 30,
1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-END>                               DEC-30-1995
<CASH>                                          23,277
<SECURITIES>                                    10,523
<RECEIVABLES>                                   18,715
<ALLOWANCES>                                       481
<INVENTORY>                                     18,811
<CURRENT-ASSETS>                                81,732
<PP&E>                                          16,240
<DEPRECIATION>                                   7,687
<TOTAL-ASSETS>                                 107,419
<CURRENT-LIABILITIES>                           23,287
<BONDS>                                            350
<COMMON>                                         1,248
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      64,993
<TOTAL-LIABILITY-AND-EQUITY>                   107,419
<SALES>                                         27,452
<TOTAL-REVENUES>                                27,452
<CGS>                                           22,665
<TOTAL-COSTS>                                   22,665
<OTHER-EXPENSES>                                   738
<LOSS-PROVISION>                                  (55)
<INTEREST-EXPENSE>                                  11
<INCOME-PRETAX>                                  1,064
<INCOME-TAX>                                       409
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       577
<EPS-PRIMARY>                                      .05
<EPS-DILUTED>                                        0
        

</TABLE>
**EXHIBIT 32.2****CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002     I, Jon F. Weber, Treasurer and Chief Financial Officer(Principal Financial Officer) of American Property Investors,Inc., the General Partner of American Real Estate Partners, L.P.(the “Registrant”), certify that to the best of myknowledge, based upon a review of the American Real EstatePartners, L.P. quarterly report onForm 10-Q for theperiod ended March 31, 2006 of the Registrant (the“Report”):     (1) The Report fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of1934, as amended; and     (2) The information contained in the Report fairlypresents, in all material respects, the financial condition andresults of operations of the Registrant.     /s/ JON F. WEBER   **Jon F. Weber**     President and Chief Financial Officer     American Property Investors, Inc.,     the General Partner of     American Real Estate Partners, L.P.Date: May 10, 2006
51
§ 522.820 Erythromycin. ( a ) *Specifications* — ( 1 ) Each milliliter (mL) of solution contains 100 milligrams (mg) erythromycin base.
( 2 ) Each mL of solution contains 200 mg erythromycin base.
( b ) *Sponsor.* See No. 061133 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.230 of this chapter.
( d ) *Conditions of use* — ( 1 ) *Dog.* Administer product described in paragraph (a)(1) of this section as follows: ( i ) *Amount.* 3 to 5 mg per pound (/lb) body weight, intramuscularly, two to three times daily, for up to 5 days.
( ii ) *Indications for use.* For the treatment of bacterial pneumonia, upper respiratory infections (tonsillitis, bronchitis, tracheitis, pharyngitis, pleurisy), endometritis and metritis, and bacterial wound infections caused by *Staphylococcus* spp., *Streptococcus* spp., and *Corynebacterium* spp., sensitive to erythromycin.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Cats.* Administer product described in paragraph (a)(1) of this section as follows: ( i ) *Amount.* 3 to 5 mg/lb body weight, intramuscularly, two to three times daily, for up to 5 days.
( ii ) *Indications for use.* For the treatment of bacterial pneumonia, upper respiratory infections (rhinitis, bronchitis), secondary infections associated with panleukopenia, and bacterial wound infections caused by *Staphylococcus* spp. and *Streptococcus* spp., susceptible to erythromycin.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 3 ) *Cattle.* Administer products described in paragraph (a) of this section as follows: ( i ) *Amount.* 4 mg/lb body weight by deep intramuscular injection once daily for up to 5 days.
( ii ) *Indications for use.* For the treatment of bovine respiratory disease (shipping fever complex and bacterial pneumonia) associated with *Pasteurella multocida* susceptible to erythromycin.
( iii ) *Limitations.* Do not use in female dairy cattle over 20 months of age. Do not slaughter treated animals within 6 days of last treatment. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. To avoid excess trim, do not slaughter within 21 days of last injection. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[72 FR 69142, Dec. 7, 2007, as amended at 79 FR 16187, Mar. 25, 2014; 84 FR 8973, Mar. 13, 2019; 88 FR 27699, May 3, 2023]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                              OCT-1-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           1,074
<SECURITIES>                                         0
<RECEIVABLES>                                   29,457
<ALLOWANCES>                                         0
<INVENTORY>                                     23,372
<CURRENT-ASSETS>                                56,032
<PP&E>                                          89,008
<DEPRECIATION>                                  49,859
<TOTAL-ASSETS>                                 115,559
<CURRENT-LIABILITIES>                           33,550
<BONDS>                                              0
<COMMON>                                        13,482
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   115,559
<SALES>                                         40,040
<TOTAL-REVENUES>                                40,040
<CGS>                                           29,134
<TOTAL-COSTS>                                   38,296
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 696
<INCOME-PRETAX>                                  1,048
<INCOME-TAX>                                       366
<INCOME-CONTINUING>                                682
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       682
<EPS-PRIMARY>                                      .12
<EPS-DILUTED>                                      .12
        

</TABLE>
Consent
of Independent Registered Public Accounting Firm










We have
issued our report dated April, 15, 2008 accompanying the consolidated financial
statements and management’s assessment of the effectiveness of internal control
over financial reporting included in the Annual Report of Astea International,
Inc. on Form 10-K for the year ended December 31, 2007.   We
hereby consent to the incorporation by reference of said report in the
Registration Statement of Astea International, Inc. and Subsidiaries on
Forms S-8 (File No. 333-107757, effective August 8, 2003, File No.
333-61981, effective August 21, 1998, File No. 333-34865 effective September 3,
1997 and File No. 333-33825, effective August 18, 1997).










/s/ Grant
Thornton LLP














Philadelphia,
Pennsylvania




April 15,
2008
Exhibit 32.1
 CERTIFICATION PURSUANT TO RULE 13a-14(b) OF
THE SECURITIES EXCHANGE ACT OF 1934
  (1)
    
    the Report fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934, as amended; and
 (2)
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 May 7, 2010
    By:
    /s/ David GoldbergDavid GoldbergPresident and Chief Executive OfficerMay 7, 2010
    By:
    /s/ Susan BraceySusan BraceyChief Financial Officer
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsReduction of Wind Tunnel Contamination During Flow Visualization Experiments Using Polystyrene MicrospheresEvaluation of novel methods and materials for seeding tracer particles for particle image velocimetry (PIV) was carried out in the Basic Aerodynamic Research Tunnel (BART) at NASA’s Langley Research Center (LaRC). Seeding of polystyrene latex microspheres (PSLs) from ethanol/water suspensions and from the dry state was carried out using custom built seeders. PIV data generated using the novel methods were found to be in general agreement with data collected using the current seeding methods. Techniques for assessing PSL fouling of wind tunnel surfaces were identified and refined. Initial results suggest that dry seeding PSLs may allow comparable data quality to wet seeding while reducing wind tunnel screen fouling. Results also indicate that further developments to the dry seeding system should focus on increasing single particle flux into the wind tunnel. Modifications to PSLs and seeding equipment to achieve this have been identified and are discussed.Document ID20190025270Acquisition SourceLangley Research CenterDocument TypeTechnical Memorandum (TM)AuthorsSchmitz, Russell C.*(North Carolina State Univ. Raleigh, NC, United States)*Genzer, Jan*(North Carolina State Univ. Raleigh, NC, United States)*Tiemsin, Pacita I.*(NASA Langley Research Center Hampton, VA, United States)*Wohl, Christopher J.*(NASA Langley Research Center Hampton, VA, United States)*Date AcquiredMay 22, 2019Publication DateApril 1, 2019Subject CategoryQuality Assurance And ReliabilityPhysics Of Elementary Particles And FieldsReport/Patent NumberNF1676L-31993NASA/TM–2019-220245L-20985Funding Number(s)WBS: 147016.03.07.01.11.02Distribution LimitsPublicCopyrightPublic Use Permitted.Available DownloadsNameType20190025270.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
#### § 19.55 Permanent disqualification of former employees.

No former Food and Drug Administration employee, including a special government employee, shall knowingly act as agent or attorney for anyone other than United States in connection with any judicial or other proceeding, application, request for a ruling or other determination, contract, claim, controversy, charge, accusation, or other particular matter involving a specific party or parties in which the United States is a party or has a direct and substantial interest and in which he participated personally and substantially through decision, approval, disapproval, recommendation, rendering of advice, investigation, or otherwise as a Food and Drug Administration employee.
39054.

#### SOUTHERN BONDED WAREHOUSE COMPANY v. ROADWAY EXPRESS, INC.

Nichols, Judge.

1. “A general demurrer goes to the whole pleading to which it is addressed, and should be overruled if any part thereof is good in substance. *Blaylock v. Hackel,*164 Ga. 257 (5) (138 SE 333).” *Calbeck v. Herrington,*169 Ga. 869, 873 (152 SE 53). “To be subject to general demurrer, a petition must be utterly lifeless. If there is a spark of life in it, it is good against such a demurrer.” *Medlock v. Aycock,*16 Ga. App. 813 (1) (86 SE 455). See also *Midland Properties Co. v. Farmer,*100 Ga. App. 8, 33 (110 SE2d 100).

(a) While on demurrer pleadings are construed most strongly against the pleader, yet they must be read as a whole and given their natural intendment. *Georgia Power Co. v. Leonard,*187 Ga. 608, 614 (1 SE2d 579).

2. A general demurrer will not reach the question of whether the proper measure of damages is alleged in a petition. See *Crawford v. Sumerau,*100 Ga. App. 499 (111 SE2d 746), and citations.

3. Either the bailor or bailee, except in the case of gratuitous bailment, may bring an action against a stranger to recover for damages to the bailed property and if the action is brought by the bailee he may recover the full damages and hold the balance, beyond his special interest, for the bailor. *Schley v. Lyon,*6 Ga. 530; *Marietta Ice & Coal Co. v. Western*& *A. R. Co.,*24 Ga. App. 725 (102 SE 182); 8 C.J.S. 371, Bailments, §56.

*459Decided September 27, 1961.

*Ben J. Camp, A. Tate Conyers,*for plaintiff in error.

*Smith', Swift, Currie, McGhee ■<& Hancock, Tom Watson Brown,*contra.

4. In the absence of a statute requiring a different interpretation, where personal property is leased the lessee of such property is a bailee for hire of such property, and an allegation that the plaintiff leased certain personal property from the owner will be construed as an allegation that the plaintiff was a bailee for hire of such property.

5. The petition alleged a cause of action against the defendant, and the trial court erred in sustaining the defendant’s general demurrer and dismissing the petition.

*Judgment reversed.*

*Carlisle,*P. *J., and Eberhardt, J., concur.*
# C_2015073EN.01001701.xml

| 2.3.2015 | EN | Official Journal of the European Union | C 73/17 |
| --- | --- | --- | --- |

2.3.2015

EN

Official Journal of the European Union

C 73/17

---

Request for a preliminary ruling from the Vestre Landsret (Denmark) lodged on 19 December 2014 — Masco Denmark ApS and Damixa ApS v Skatteministeriet

(Case C-593/14)

(2015/C 073/23)

Language of the case: Danish

Referring court

Vestre Landsret

Parties to the main proceedings

Applicants: Masco Denmark ApS and Damixa ApS

Defendant: Skatteministeriet

Question referred

‘Does Article 43 EC, read in conjunction with Article 48 EC (now Article 49 TFEU, read in conjunction with Article 54 TFEU), preclude a Member State from not allowing a resident company a tax exemption for interest income where an affiliated company within the same group established in another Member State is not entitled to a tax deduction for the corresponding interest expenditure as a result of rules (as in the present case) in the relevant Member State on interest deduction limitation in cases of thin capitalisation, where the Member State allows a resident company a tax exemption for interest income in cases where an affiliated company within the same group in that same Member State is not allowed a tax deduction for the corresponding interest expenditure as a result of national rules (as in the present case) on interest deduction limitation in cases of thin capitalisation?’

---
Exhibit 31.1



CERTIFICATION



I, Craig H. Muhlhauser, certify that:



1. I have reviewed this Quarterly Report on Form 10-Q of Exide Technologies;



2. Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the registrant and we have:



a. Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;



b. Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and



c. Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the most recent fiscal quarter (the registrants fourth fiscal quarter in the case of
an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation
of internal control of financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function):



a. All significant deficiencies and material weaknesses in
the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



b. Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrants internal control over financial reporting.



|    |  |                                                          
|--- |  | ---------------------------------------------------------
|By: |  | /s/    CRAIG H.
MUHLHAUSER                               
|    |  | Craig H. Muhlhauser President and Chief Executive Officer



Date: August 11, 2004